These studies provide strong evidence that EA treatment exerts anti-apoptotic effects by upregulating the expression of Bcl-2 and downregulating the expression of caspase-3 in the cerebral ischemia model of cerebral ischemia. Here, BCL2 is linked to brain ischemia.